Register Now for NAAF's 39th Annual Patient Conference June 27-30, 2024 in Washington, D.C.!

What’s New In Pediatric Alopecia Areata Treatment?

Speaker: Brittany Craiglow, MD Date Aired: January 10, 2024

In 2023, the FDA approved the first treatment for alopecia areata in adolescents. Pediatric dermatologist Brittany Craiglow, MD, will bring us up to date on alopecia areata in children and the current treatment landscape. 

Note on clinical trials: Dr. Craiglow discussed clinical trial participation in her presentation. To learn more about clinical trials, visit NAAF’s Clinical Trials and Research Studies page or click the links below for specific trials:

Olumiant study: Study of Baricitinib in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata (BRAVE-AA-PEDS) – currently recruiting

Rinvoq study: A Study to Evaluate the Safety and Effectiveness of Upadacitinib (Rinvoq) Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up-AA) – currently recruiting

Dupixent study: Dupilumab in the Treatment of Pediatric Alopecia Areata – recruitment expected to begin March 2024.